Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults3 Aug 2026

Kansai Nerolac Paints Ltd

This is to inform you that the Board of Directors of Kansai Nerolac Paints Limited has, in its meeting held today i.e. on Monday, 3rd August, 2026, inter alia considered and approved the ....

Kansai Nerolac Paints Ltd's Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and the company's management is responsible for the preparation of the statement in accordance with Indian Accounting Standard 34.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults3 Aug 2026

Computer Age Management Services Limited

Investor Presentation

Computer Age Management Services Limited has informed the Exchange about Investor Presentation, presenting Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, with EBITDA growing 18.3% Y-o-Y to ₹183 Cr. and PAT growing 17.3% Y-o-Y to ₹128 Cr.

Read more →📎 1 attachment
NSEInvestor PresentationResults3 Aug 2026

GlaxoSmithKline Pharmaceuticals Limited

Investor Presentation

GlaxoSmithKline Pharmaceuticals Limited has presented its investor presentation, highlighting its Q1 FY27 financial performance, which saw revenue growth of 15% and EBITDA margin expansion of 50 bps, driven by execution excellence and portfolio transformation. The company's key brands maintained their competitive performance, and the vaccine segment continues to lead the market.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults3 Aug 2026

GlaxoSmithKline Pharmaceuticals Ltd

Presentation

GlaxoSmithKline Pharmaceuticals Ltd has announced its Q1 FY27 results, with revenue growing 15% YoY to ₹924cr, EBITDA margin expanding 50bps to 31.7%, and PAT margin increasing 200bps to 27.6%. The company's key brands maintained their competitive performance in the market, with Gen Meds and Vx portfolios leading the growth.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults3 Aug 2026

GKW Limited

Outcome of Board Meeting

GKW Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹1,487.50 lakhs and a profit before tax of ₹1,311.93 lakhs.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults3 Aug 2026

Kansai Nerolac Paints Limited

Outcome of Board Meeting

The Board of Directors of Kansai Nerolac Paints Limited has approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026. The results were reviewed by the Statutory Auditors, and necessary arrangements have been made for publishing the results in the newspapers.

Read more →📎 1 attachment
BSECompany UpdateResults3 Aug 2026

Tata Chemicals Ltd

Transcript of Analysts/Investor Call pertaining to the Financial results for the quarter ended June 30, 2026.

Tata Chemicals Ltd has announced its Q1FY27 earnings, with a significant accounting change to align its segment reporting with its business operations. The company has renamed its segments to Living, Industry, and Farm Essentials, with Farm Essentials comprising Rallis and Morocco. The company has highlighted stable demand in Living Essentials, particularly in food, feed, and pharma, and a challenging near-term outlook for Industrial Essentials due to global oversupply and cost pressures.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults3 Aug 2026

Aditya Birla Lifestyle Brands Limited

Copy of Newspaper Publication

Aditya Birla Lifestyle Brands Limited has published a newspaper advertisement regarding its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSEAGM/EGMResults3 Aug 2026

Jenburkt Pharmaceuticals Ltd

Notice of the 41st Annual General Meeting of the Company Schedule to be held on Friday, 04th September, 2026, through VC/OAVM.

Jenburkt Pharmaceuticals Ltd has announced the notice of its 41st Annual General Meeting (AGM) to be held on September 4, 2026, through video conferencing. The meeting will consider various resolutions, including the adoption of audited financial statements, dividend declaration, and reappointment of the Whole Time Director and CFO.

Read more →📎 1 attachment
BSEBoard MeetingResults3 Aug 2026

PCS Technology Ltd

PCS Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial Result (Standalone ....

PCS Technology Ltd has scheduled a board meeting on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The trading window for dealing in securities of the company will remain closed until 48 hours after the financial results are declared.

Read more →📎 1 attachment
← PreviousPage 1450 of 2185Next →